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INTRODUCTION
Squamous cell carcinoma (SCC) of the oral cavity is typically
seen after the fifth decade of life, and it is the sixth most com-
mon cancer in the world (1). Less than 4% of these lesions occur
in patients younger than 40 years old (2). However, oral cavity
cancers in younger patients have recently increased, and espe-
cially in female patients who do not consume alcohol or tobac-
co (3). Oral cavity cancers in younger patients have been sug-
gested to show different clinical characteristics and disease pro-
gression from that seen in older patients (4). Son and Kapp (2),
Amsterdam and Strawitz (5), and Sasaki et al. (6) concluded that
the young patients have worse clinical outcomes than do the older
patients. However, Friedlander et al. (7) and Pitman et al. (8)
noted no significant difference in outcome between different age
groups, and McGregor et al. (9), Clark et al. (10), and Hafkamp
et al. (11) reported better outcomes in the younger age groups.
Thus, the previous studies have reported conflicting results
about the clinical characteristics of oral cavity cancer in the young
Objectives. The reported incidence of tongue cancer in young patients has recently increased. The aim of this study was to
analyze the clinical characteristics of tongue cancer in a young group of patients, and to compare them with those of
an older group of tongue cancer patients. 
Methods. We retrospectively reviewed the records of 85 patients who were diagnosed with squamous cell carcinoma of
the tongue. They were divided into two age groups: over 45 years of age and under 45 years. To compare the prog-
nosis of similarly staged patients in the group, each age group was divided into the early (stage I, II) and advanced
stage groups (stage III, IV), and then they were compared. The young group consisted of 23 patients and the older
group had 62 patients.
Results. At the early stage, the clinical prognosis of the patients in both age groups was good, and no significant difference
was observed. However, at the advanced stage, the overall and regional recurrence rates were significantly higher
in the younger age group as compared to that in the old age group (P=0.007, P=0.001, respectively). The disease-
specific survival rate of the patients in the young group was significantly lower than that in the old age group (P=
0.025). 
Conclusion. Tongue cancer in young subjects has significantly different clinical outcomes according to the stage. The clini-
cal outcome of the advanced-stage tongue cancer in young subjects was poorer than that in the older subjects.
Regional recurrence seemed to be the main cause of the poor prognosis. 
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In addition, there is a lack of reports that have compared between
different age groups.
The purpose of this study was to analyze the recurrence and
survival rates of SCC of the tongue in young patients who are
under 45 years of age, and to compare them with older patients
who have SCC of the tongue and who are over the age of 45
years.
MATERIALS AND METHODS
We retrospectively reviewed 105 patients who were treated for
SCC of the tongue at our hospital between December 1994
and September 2008. Eighty-five patients were included who
had not been treated before hospitalization for the same diag-
nosis, and they received their initial surgical treatment with a
curative intent and a minimum follow up of 12 months. Twenty
patients did not have sufficient data and they were excluded.
Primary resection and neck dissection with an en bloc pattern
was the surgical treatment for most patients in both groups.
Selective neck dissection was done with a prophylactic intent
for the clinically negative necks, and modified radical neck dis-
section was done for the clinically positive necks. In the limited
cases of early cancer (<1 cm), primary resection was done with-
out neck dissection. Adjuvant treatment was considered when
the cancer free margin was insufficient (<5 mm) or when extra-
capsular invasion was found, or if multiple nodal metastases
were found. Most patients were followed-up every 6 months
for the first 2 years and then they were followed up every 12
months. The follow-up modalities were computed tomography
(CT), magnetic resonance imaging (MRI) and a liver/bone scan
or positron emission tomography (PET)/CT. 
The study group was divided into two age groups with a cut-
off level of 45 years. The following data was recorded from the
patient files: age, gender, tobacco and alcohol consumption,
staging, pathology, the treatment modalities, the length of the
hospital stay and the clinical outcome. To evaluate the clinical
outcome, we analyzed the recurrence rate, the site of recurrence
and the overall and disease specific survival rates. The patients
were staged according to the 2002 American Joint Committee
on Cancer (AJCC) staging system. The institutional review
board approved the retrospective review of the medical records.
Statistical analyses
To analyze the significance of the relationships between the
two age groups and the clinical factors (such as gender, tobacco
and alcohol consumption, TN stage, tumor cell differentiation,
treatment modalities and the clinical outcomes), the chi-square
test and Fisher’s exact test were used, as appropriate. The recur-
rence rate was evaluated and compared using the Kaplan-Meier
method and the log-rank test. The overall survival was deter-
mined and compared using the Kaplan-Meier method and the
log-rank test. P-values <0.05 were deemed to indicate statistical
significance. All the calculations were performed using SPSS
ver. 13.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Patient characteristics
The young group consisted of 23 patients and the older group
was comprised of 62 patients. The median age was 54.5 years
(range, 23 to 86 years) with 51 men and 34 women. In the young
age group (age <45 years), the median age was 38.0 years (range,
23 to 45 years) with 11 men and 12 women. In the older group
(age ≥45), the median age was 62 years (range, 46 to 86 years),
with 40 men and 22 women. The female:male ratio was not sig-
nificantly different between the groups (P=0.126). Tobacco
consumption was lower in the young group than that in the
older group, but the difference was not significant (P=0.084).
Alcohol consumption was significantly lower in the young
group (P=0.036) (Table 1). The follow-up period ranged from
12 to 159 months (mean, 48 months) in the young group and
12 to 170 months (mean, 54 months ) in the older age group. 
Stages and pathologic characteristics
Regarding the pathological stages, no significant difference
existed between the groups in terms of the T or N stage (P=0.542
and P=0.308, respectively). Regarding the tumor cell differenti-
ation, there were no significant differences between the groups
(P=1.000).
Treatment modalities and clinical outcomes
The treatment modalities were recorded for all the patients:
surgery alone was done in 17 patients (73.9%), surgery follow-
ing adjuvant radiotherapy was done in zero patients (0%),
surgery following adjuvant chemotherapy was done in one
patient (4.3%), and surgery and adjuvant concurrent chemother-
apy and radiotherapy were done in five patients (21.5%) in the
young group; in the older group, surgery alone was done in 44
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Parameters
Young group Older group
P-value
(n=23) (n=62)
Table 1. Gender and habits of both age groups
Values are presented as number (%).
*P-value <0.05.
Gender
Male 11 (47.8) 40 (64.5) 0.126
Female 12 (52.2) 22 (35.5)
Habits
Smoking 5 (21.7) 27 (43.5) 0.084
Alcohol 6 (26.1) 25 (40.3) 0.036*Park J-O et al.: Squamous Cell Carcinoma of Tongue in Young Patients 163
patients (71.0%), surgery following adjuvant radiotherapy was
done in seven patients (11.3%), surgery following adjuvant
chemotherapy was done in one patient (1.6%), and surgery
and adjuvant concurrent chemotherapy and radiotherapy were
done in ten patients (16.1%). No significant difference existed
between the groups (P=0.273).
Regarding neck treatment, seven (30.4%) and 16 (69.6%)
patients had bilateral neck dissection and unilateral neck dissec-
tion, respectively, in the young group, and 22 (35.5%) and 40
(64.5%) patients, respectively, did so in the older group. No
significant difference existed between the groups (P=0.310).
Concerning surgical complications, one (4.3%) and two (8.7%)
patients had flap failure and fistula, respectively, in the young
group, and one (1.6%) and one (1.6%) patients had postopera-
tive bleeding and wound infection, respectively, in the older group.
Twenty-seven patients experienced recurrences or metas-
tases. In the young group, three (13.0%) cases were at the pri-
mary site, eight (34.8%) were in the neck and no case of distant
metastasis was observed. In the older group, five (8.1%) cases
were at the primary site, five (8.1%) cases were in the neck,
and six (9.7%) cases had distant metastases. The 5 years-over-
all recurrence rate was 58.3% in the young group and 46.3%
in the older group. The recurrence rate was significantly higher
in the young group (P=0.025*). The 5 years-regional recurrence
rate was 47.0% in the young group and 11.2% in the older
group. The regional recurrence rate was significantly higher in
the young group (P=0.001*) (Table 2).
Survival rate and the associated factors
The final outcomes of the 85 patients were as follows: 18 patients
died as a result of the disease, eight died from other causes and
59 survived with no further evidence of disease. The patients
who were followed for more than 12 months had 5-years over-
all survival and disease-specific survival rates of 68.7% and
76.2%, respectively. The 5-years disease-specific survival rate
was 65.6% in the young group and 71.0% in the older group;
this difference was not significant (P=0.124) (Fig. 1).
Stage-matching analysis and the prognosis
Regarding the cancer staging, 14 (60.8%) patients were at an
early stage (stage I, II) in the young group, and 37 (59.7%)
patients were at an early stage in the older group. The young
group had nine (39.2%) advanced-staged patients (stage III,
IV), and the older group had 25 (40.3%) such patients. To com-
pare the prognosis of the similarly staged patients between the
groups, each age group was divided into the early- (stage I, II)
and advanced-stage subgroups (stage III, IV), and these subgroups
were compared.
In the early-stage subgroup, nine (17.6%) patients experienced
recurrences or metastases. In the young group, one (7.1%) case
was at the primary site and two (14.3%) cases were in the neck,
and there was no case of distant metastasis. In the older group,
three (8.1%) cases were at the primary site, two (5.4%) were
in the neck and one (2.7%) case had a distant metastasis. The 5
years-overall recurrence rate was 35.0% in the young group
and 32.1% in the older group. No significant difference was
observed between the groups (P=0.540) (Table 3). The 5-years
disease-specific survival rate of the patients in the young group
was 92.9%, and that in the older group was 92.5%. No signifi-
cant difference in the disease-specific survival rate was observed
between the groups (P=0.966) (Fig. 2).
Parameters
Young group Older group
P-value
(n=23) (n=62)
Table 2. Stages and recurrence of both age groups
Stage, no (%)
I-II 14 (60.8) 37 (59.7)
III-IV 9 (39.2) 25 (40.3)
5-years recurrence rate (%) 58.3 46.3 0.025*
Local 21.0 18.4 0.280
Regional 47.0 11.2 0.001*
Distant                                          0 16.0 0.186
Fig. 1. Kaplan-Meier disease-specific survival curve by the age group.
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Table 3. Individual comparison of the prognosis of the early
stages (stage I, II) for both age groups
Early 5-years recurrence rate 35.0 32.1 0.540
(stage Local 12.5 20.0 0.990
I, II) Regional 25.71 9.3 0.260
Distant 0 4.7 0.590
Disease-specific   92.9 92.5 0.966
5-years survival rate
*P-value <0.05.164 Clinical and Experimental Otorhinolaryngology  Vol. 3, No. 3: 161-165, September 2010
In the advanced-stage subgroup, 18 (52.9%) patients had
recurrences or metastases. In the young group, two (22.2%)
cases were at the primary site, six (66.7%) cases were in the
neck and no case had a distant metastasis. In the older group,
two (8.0%) cases were at the primary site, three (12.0%) were
in the neck and five (20.0%) cases of distant metastases occurred.
The 5 years-overall recurrence rate was 88.9% in the young
group and 53.5% in the older group. The 5-years regional
recurrence rate was 83.3% in the young group and 14.1% in
the older group. The recurrence rate of the patients in the young
group was significantly higher than that of the older group
(P=0.007*), and especially for regional recurrence (P=0.001*)
(Table 4). The 5-years disease-specific survival rate of the patients
in the young group was 25.4%, whereas that in the older group
was 60.5%. The disease-specific survival rate in the young
group was significantly lower than that of the older group
(P=0.025*) (Fig. 3). 
DISCUSSION
SCC of the oral cavity is a rare disease in young people; fewer
than 4% of these lesions occur in patients younger than 40 years
of age (2). About 30% of the patients with SCC of the oral cavi-
ty have been reported to be younger than 45 years (12, 13). 
Oral cavity cancers in young patients have recently increased,
and especially in female patients who do not consume alcohol
or tobacco. This disease has been suggested to show different
clinical characteristics and disease progression from that in older
patients (4). Atula et al. (14) in Finland found that the percent-
age of SCC of the tongue occurring in young adults had increased
from 3% per year for the decade between 1953 to 1962 to 7%
annually for the decade between 1983 to 1992. Lingen et al.
(15) revealed that an increased p53 expression without a muta-
tion in exon 5-9 was found in the SCC of the oral cavity in
young, nonsmoking patients. Sorenson et al. (16) showed that
the p53 mutation was less common in the tongue cancer of
young patients with no history of alcohol or tobacco use.
We divided the patients who were diagnosed with SCC of
the tongue into two age groups: over and under 45 years of
age. We decided on this cutoff age based on the previous stud-
ies (2, 17). About 27% of the patients were under 45 years in
our study group, and this was consistent with the previous stud-
ies (12-14).
Our findings were consistent with previous studies reporting
that alcohol and tobacco use were less common in younger
patients. No significant difference in smoking could be assessed
due to the lack of data for some patients.
Friedlander et al. (7) and Pitman et al. (8) noted no signifi-
cant difference in the outcome between different age groups.
However, McGregor et al. (9), Clark et al. (10), and Hafkamp
Fig. 2. Kaplan-Meier disease-specific survival curve by the age group
among the early-stage patients. 
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Fig. 3. Kaplan-Meier disease-specific survival curve by the age group
among the advanced-stage patients.
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Table 4. Individual comparison of the prognosis of advanced
(stage III, IV) stages for both age groups
Stage Parameters
Young group Older group
P-value
(n=9) (n=25)
Advanced 5-years recurrence rate 88.9 53.5 0.007*
(stage Local 31.4 16.0 0.073
III, Iv) Regional 83.3 14.1 0.001*
Distant                              0 35.5 0.288
Disease-specific 25.4 60.5 0.025*
5-years survival rate
*P-value <0.05.Park J-O et al.: Squamous Cell Carcinoma of Tongue in Young Patients 165
et al. (11) noted that the outcome of the younger group was
better. Son and Kapp (2), Amsterdam and Strawitz (5), and
Sasaki et al. (6) concluded that younger patients had worse clin-
ical outcomes than did the older patients. Vargas et al. (18), in
their study of 17 young females with invasive SCC of the tongue,
they found that young women with SCC of the anterior tongue
had significantly higher rates of recurrent disease and that the
interval to recurrence was significantly shorter than that of older
patients. The conflicting and inconsistent results of the previous
reports seem to be due to the small numbers of patients in the
young groups.
Our current report is partially consistent with the studies that
found a worse prognosis in younger patients with tongue can-
cer. In the early-stage group, the recurrence rate was low and
the survival rate was high for all ages. However, in the advanced-
stage group, the recurrence rate was higher for the young patients,
and especially for regional recurrence. In total, eight (88%)
recurrent cases were seen in the young patients. There were six
(66%) regional recurrences in the young patients, two of which
were exclusively in the contralateral neck (level I, II). In the
ipsilateral neck, there were four regional recurrences, and all of
them were in level I. Regarding the possible cause of recurrence,
two cases were treated by ipsilateral selective neck dissection
with a prophylactic intent because of the clinical N0 stage.
Subsequently, they were pathologic N2 stage and they recurred
in the contralateral neck. Ipsilateral selective neck dissection is
thought to be insufficient to eradicate neck disease. Three of
the recurrent cases had multiple positive nodes pathologically
(more than 13), and extracapsular invasion was found and they
all recurred in level I. In one case, we found no obvious reason
for recurrence. In two locally recurrent cases, the lack of a can-
cer-free margin was thought to be the reason for recurrence.
As noted previously, failure of regional control seemed to be
the main cause of a poor prognosis in the young group. In the
recurrent cases, the nodal disease was more aggressive than we
had staged preoperatively. Thus, we think that more aggressive
neck treatment may have prevented regional recurrence.
However, a limitation of this study is its small sample size, and
a larger multicenter study is needed.
According to our results, when the cancer is at an early stage,
the outcome is similar at all ages, but as the cancer progresses,
it transformed to a more aggressive form in the younger patients.
This may have been due to different carcinogenesis at the gene
level, so molecular studies would be useful. 
In conclusion, tongue cancer at a young age has significantly
different clinical outcome according to the tumor stage. Because
advanced-stage tongue cancer leads to morbidity with a poor
overall outcome and especially in young patients, it is impor-
tant to detect it at an early stage. Regional recurrence seems to
be main cause of the poor prognosis, and so we cautiously rec-
ommend that more complete neck treatment is needed.  
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